00:00President Donald Trump announced sweeping agreements with Eli Lilly and Novo Nordis
00:04to dramatically cut prices on popular weight loss drugs like ZepBound and WeGovi.
00:10Starting next year, out-of-pocket costs could drop to as low as $50 a month,
00:14compared to today's prices above $1,000.
00:18Medicare will, for the first time, cover GLP-1 drugs for obesity beginning mid-2026,
00:24potentially expanding access to millions of seniors.
00:27The deal also launches TrumpRx, a new direct-to-consumer platform
00:32offering even steeper discounts and fast-track reviews for new obesity drugs.
Comments